ClinicalTrials.gg
RecruitingNCT02417714Updated Nov 20, 2026

Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)

An observational study in Healthy Subjects, sponsored by National Heart, Lung, and Blood Institute (NHLBI). Recruiting at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by National Heart, Lung, and Blood Institute (NHLBI) · Observational

How we know

From the registry’s dates

  • Started Sep 2014; still recruiting 12 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
215
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Background:

- Computed Tomography (CT) is a scan that makes detailed pictures of the body. It uses radiation to do that. In 2011, about 85.3 million CT scans were done in the United States. But there is growing concern about the health effects of radiation. There are new and different ways to make CT pictures that use less radiation. Researchers want to learn whether these new methods create images that are similar to images from a traditional CT.

Objective:

- To learn if new CT imaging methods with less radiation make images that are similar to traditional ways.

Eligibility:

- Adults 18 years of age and older who are scheduled for a CT of the chest, abdomen and pelvis with contrast.

Design:

  • Researchers will review participants medical records to see if they can be in this study.
  • Participants may have blood drawn from an arm vein by a needle stick. The blood will be used to make sure they can be in this study and that it is safe for them to have contrast.
  • During the participants CT scan appointment, one extra scan will be done using low radiation methods.
  • During a CT scan, the participant lies on a table. A large x-ray machine takes pictures of the body.
Read the detailed description

Computed Tomography uses ionizing radiation to make pictures of the body. Different methods of creating CT pictures have been developed that allow reductions in the amount of radiation. The purpose of this research study is to learn whether these new imaging methods using less radiation to create images are similar to the traditional and current method.

02

Conditions studied

  • Healthy Subjects

Keywords

  • Computed Tomography
  • Radiation Reduction
  • Iterative Reconstruction
  • Natural History
03

In context

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI) is the lead sponsor of 1,144 studies on the registry; 71 are open to participants now.

Of its 58 completed or terminated interventional studies of FDA-regulated products, 51 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be enrolled at the NIH Clinical Center. A total of 215 subjects will be enrolled. Subjects will be recruited from the NIH Clinical Center radiology department from subjects scheduled to have a CT scan of the chest, abdomen and pelvis with contrast.

Eligibility criteria

  • INCLUSION CRITERIA:

Inclusion Criteria for Body CT:

  1. Clinical indication for a chest, abdomen and pelvis CT with contrast
  2. Age equal to or greater than 18 years
  3. Able to understand and willing to sign the Form

Inclusion Criteria for Chest CT:

  1. Clinical indication for a CT with or without contrast that includes the chest
  2. Age equal to or greater than 18 years
  3. Able to understand and willing to sign the Informed Consent Form

EXCLUSION CRITERIA:

Exclusion Criteria for Body CT:

  1. Pregnancy
  2. Serum Cr > 1.5 mg/dL
  3. Clinical CT scan with more than one contrast imaging phase (for example three phase liver)

Exclusion Criteria for Chest CT

1. Pregnancy

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
215 participants (estimated)

Groups and cohorts

  • Body CT group

    100 subjects for a body CT

  • Chest Ct Group

    115 subjects for a chest CT

06

What researchers measure

Primary outcomes

  1. Compare with respect to 6 image quality metrics the overall image quality from a research low radiation dose body CT utilizing advanced (model based) iterative reconstruction with a clinical standard radiation dose CT from the same subject.

    Time frame: Baseline (Day 0)

07

Study locations

1 of 1 sites recruiting
  • National Institutes of Health Clinical Center
    Bethesda, Maryland 20892, United States
    Recruiting
    • NIH Clinical Center Office of Patient Recruitment (OPR) · Contactccopr@nih.gov · 800-411-1222
08

References and documents

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2014 (actual). Primary completion is estimated for Sep 2027, 156 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 15, 2015
First posted
Apr 16, 2015
StartActual
Sep 8, 2014
Primary completionEst.
Sep 22, 2027
CompletionEst.
Sep 22, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02417714
Responsible party
Sponsor
First posted
Apr 16, 2015
Start date
Sep 8, 2014
Primary completion
Sep 22, 2027 (estimated)
Completion
Sep 22, 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Margaret C Lowery, R.N.
Contact
peg.lowery@nih.gov
(301) 412-9255
Marcus Y Chen, M.D.
Contact
chenmy@mail.nih.gov
(301) 496-0077
Marcus Y Chen, M.D.
principal investigator · National Heart, Lung, and Blood Institute (NHLBI)

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion